Halozyme Therapeutics, Inc.

NEW YORK STATE COMMON RETIREMENT FUND HALO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

60,604

Value ($000)

4,079

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	4,079	0.0%	60,604	12/31/2025
2025 Q3	11/3/2025	4,630	0.0%	63,127	9/30/2025
2025 Q2	10/8/2025	12,847	0.0%	246,966	6/30/2025
2025 Q1	10/8/2025	19,143	0.0%	300,001	3/31/2025
2024 Q4	10/8/2025	17,595	0.0%	368,010	12/31/2024
2024 Q3	10/8/2025	44,046	0.1%	769,504	9/30/2024
2024 Q2	10/8/2025	50,110	0.1%	957,019	6/30/2024
2024 Q1	10/8/2025	37,334	0.0%	917,759	3/31/2024
2023 Q4	10/8/2025	35,087	0.0%	949,324	12/31/2023
2023 Q3	10/8/2025	37,054	0.1%	969,999	9/30/2023
2023 Q2	10/8/2025	34,244	0.0%	949,387	6/30/2023
2023 Q1	10/8/2025	31,631	0.0%	828,250	3/31/2023
2022 Q4	10/8/2025	45,525	0.1%	800,091	12/31/2022
2022 Q3	11/8/2022	37,860	0.1%	957,511	9/30/2022
2022 Q2	8/4/2022	42,777	0.1%	972,197	6/30/2022
2022 Q1	7/1/2022	42,870	0.0%	1,074,977	3/31/2022
2021 Q4	2/2/2022	50,642	0.1%	1,259,450	12/31/2021
2021 Q3	11/2/2021	71,162	0.1%	1,749,309	9/30/2021
2021 Q2	8/2/2021	73,352	0.1%	1,615,323	6/30/2021
2021 Q1	5/11/2021	69,962	0.1%	1,678,138	3/31/2021
2020 Q4	2/8/2021	68,224	0.1%	1,597,382	12/31/2020
2020 Q3	11/5/2020	43,668	0.1%	1,661,656	9/30/2020
2020 Q2	8/7/2020	44,549	0.1%	1,661,656	6/30/2020
2020 Q1	5/6/2020	27,678	0.0%	1,538,499	3/31/2020
2019 Q4	2/5/2020	15,567	0.0%	878,019	12/31/2019